Haemonetics
245 hedge funds and large institutions have $3.58B invested in Haemonetics in 2021 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 89 increasing their positions, 93 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
5% less funds holding
Funds holding: 258 → 245 (-13)
24% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 42
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
245
Holding in Top 10
2
Calls
$24.2M
Puts
$24.3M
Top Buyers
| 1 | +$71.4M | |
| 2 | +$39.7M | |
| 3 | +$39M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$36.2M |
| 5 |
RA
Royce & Associates
New York
|
+$27M |
Top Sellers
| 1 | -$109M | |
| 2 | -$40.6M | |
| 3 | -$34.8M | |
| 4 |
Renaissance Technologies
New York
|
-$33.2M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
-$25.5M |